Anthony Kirck
Comptroller/Controller/Auditor at OPTINOSE, INC.
Net worth: 154 833 $ as of 2024-05-30
Anthony Kirck active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 2021-10-31 | - |
Career history of Anthony Kirck
Former positions of Anthony Kirck
| Companies | Position | Start | End |
|---|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 2020-01-31 | 2021-10-31 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 2017-05-31 | 2020-01-31 |
Training of Anthony Kirck
| Albright College | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Stock Market
- Insiders
- Anthony Kirck
- Experience
